Clinical trial
Dexamethasone Intra-Erythrocyte Therapy in Patients With Chron's Disease or Ulcerative Colitis
NCT01171807 is registered in ClinicalTrials.gov with Quince Therapeutics S.p.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dexamethasone Intra-Erythrocyte Therapy in Patients With Chron's Disease or Ulcerative Colitis
- Lead sponsor
- Quince Therapeutics S.p.A.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 22, 2003
- Completion date
- May 15, 2007
- Enrollment
- 33 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ulcerative colitis